Polypharmacy and Mortality Among Nursing Home Residents With Advanced Cognitive Impairment: Results From the Shelter Study
- 6 May 2013
- journal article
- research article
- Published by Elsevier BV in Journal of the American Medical Directors Association
- Vol. 14 (6), 450.e7-450.e12
- https://doi.org/10.1016/j.jamda.2013.03.014
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's DiseaseThe New England Journal of Medicine, 2012
- Predictors of Hospitalization in Italian Nursing Home Residents: The U.L.I.S.S.E. ProjectJournal of the American Medical Directors Association, 2012
- The Central Role of Prognosis in Clinical Decision MakingJama-Journal Of The American Medical Association, 2012
- Assessment of nursing home residents in Europe: the Services and Health for Elderly in Long TERm care (SHELTER) studyBMC Health Services Research, 2012
- Physician Intervention for Medication Reduction in a Nursing Home: The Polypharmacy Outcomes ProjectJournal of the American Medical Directors Association, 2011
- The Advanced Dementia Prognostic Tool: A Risk Score to Estimate Survival in Nursing Home Residents with Advanced DementiaJournal of Pain and Symptom Management, 2010
- Prediction of 6-Month Survival of Nursing Home Residents With Advanced Dementia Using ADEPT vs Hospice Eligibility GuidelinesJama-Journal Of The American Medical Association, 2010
- Polypharmacy and Potentially Inappropriate Medication Use Among Community-dwelling Elders With DementiaAlzheimer Disease & Associated Disorders, 2010
- Development of CRIteria to Assess Appropriate Medication Use among Elderly Complex Patients (CRIME) ProjectDrugs & Aging, 2009
- Polypharmacy Status as an Indicator of Mortality in an Elderly PopulationDrugs & Aging, 2009